Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
🧠 People often say they want big wins (like lotteries), but in practice, they choose what wins more often—even if it pays less. 🎮 In experiments, when outcomes are shown side-by-side, we tend to favor the “frequent winner.” 📉 This bias can make us overlook rare, high rewards—shaping real-world choices in money, health, and risk. 🔍 Bottom line: It’s not just what we choose, but how the choice is shown that changes everything.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Zhuang Zhou, also known as Zhuangzi, was an influential 4th-century BCE Chinese philosopher during the Warring States period. As a foundational figure of Taoism, he authored the Zhuangzi, a text known for its profound philosophical insights, parables, and critiques of societal norms, emphasizing personal freedom and harmony with the Tao. His ideas remain central to Chinese philosophy and continue to inspire discussions on ethics, metaphysics, and human nature.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
🧴 Delgocitinib cream outperformed oral alitretinoin in treating severe chronic hand eczema over 24 weeks. 📉 Greater reduction in HECSI, 😊 better quality of life, and ⚠️ fewer side effects make it a promising non-steroidal alternative. 💊 Time to rethink systemic pills — topical wins hands down! 🖐️✅
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
🧬 Human pelvic evolution reflects a tug-of-war between 🚶♀️ efficient walking, 🧠 growing brains, and 🚼 safe childbirth. Using AI and genetic data from 31,115 individuals, Xu et al. found the pelvis is highly heritable, sex-dimorphic, and shaped by multiple selective pressures—not just bipedalism or birth. Larger canals ease delivery but risk 💥 pelvic floor disorders, while narrower ones boost mobility but raise ⚠️ labor complications. This study reframes the “obstetrical dilemma” as a 🔄 multifactorial evolutionary compromise.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
🩸 Summary: Lung interstitial macrophages, activated by tumor-derived CXCL13, release integrin β2⁺ extracellular vesicles (sEVs) 🧬 that bind platelet GPIb 🧲, triggering clot formation across the body. These sEVs are both a driver of cancer-associated thrombosis and a potential biomarker for early risk detection 🎯, offering safer, targeted therapeutic opportunities 💉.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Cancer cachexia isn’t just weight loss—it’s a hijacking of motivation 😔. Elevated IL-6 🔥 activates a brainstem-to-basal ganglia circuit 🧠 that suppresses dopamine 💊 in the nucleus accumbens, leading to effort-based apathy 💤. Blocking IL-6 or boosting dopamine restores drive without changing weight, revealing a treatable neuroimmune pathway 💡.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
🧪 SMART-CHOICE 3 in a Nutshell 🟣 Clopidogrel beat 🟠 aspirin post-PCI: 📉 Fewer MACCE (4.4% vs 6.6%) 🩸 Same bleeding risk 🍽️ Fewer GI events ⚠️ Editorial: Fragile stats, late benefit, open questions on lifelong therapy. 🎯 Verdict: Promising—but not bulletproof.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
🔋 Mitochondrial transplants are emerging as a powerful therapy to repair damaged cells, boost energy, and even reverse aging. From saving 🫀 baby hearts to protecting 🧠 stroke-affected brains, this tiny powerhouse may revolutionize medicine—one cell at a time. 🧬💉✨
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Plato (c. 428-348 BCE), a foundational figure in Western philosophy, was a student of Socrates and teacher of Aristotle. He established the Academy in Athens and is known for his theory of Forms, dialogues on justice, ethics, and politics, and lasting influence on philosophy, science, and education.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
🧬 Mitochondria are on the move! Once thought to stay put, these powerhouses travel between cells 🚀—healing neurons 🧠, boosting immunity 🛡️, and even aiding cancer cells ⚠️. Scientists are now exploring how to harness this dynamic dance for future therapies 💉.
info_outlineRecent randomized trials, including EARLY TAVR, AVATAR, RECOVERY, and EVOLVED, suggest benefits of early aortic valve replacement (AVR) in asymptomatic severe aortic stenosis (AS).
Early AVR reduces stroke, heart failure hospitalizations, and cardiovascular events, with a trend toward improved survival.
The data support shifting from clinical surveillance to early intervention?